Article: Flu Season: FDA Approves More Effective mRNA Shot for Adults 50 and Up

The Food and Drug Administration (FDA) has approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. The new flu shot, called mFLUSIVA, is highly effective in preventing serious illness in adults ages 50 to 64.